Insurers look to negotiate CSAs ahead of new clearing rules

Insurers are seeking greater protection for their derivatives trades, but efforts to renegotiate credit support annexes with counterparties are proving to be protracted and insurers are looking at ways to sidestep new regulatory burdens. Blake Evans-Pritchard reports

handshake-moneybox

Insurers look to negotiate CSAs ahead of new clearing rules

Page 1
Page 1

Insurers look to negotiate CSAs ahead of new clearing rules

2

3

4

From the middle of next year, a great many derivatives trades will have to go through a central counterparty (CCP) as regulators push to make such transactions safer. But some will still remain beyond the remit of centralised clearing, and will continue to be negotiated bilaterally in so-called over-the-counter deals. Exactly what to do about these, and how to strip out credit risk, is proving a particular headache for insurance companies.

To a large extent, life insurers have no choice. The Dodd-Frank Act in the US and the European Market Infrastructure Regulation in Europe have toughened requirements on the collateral that firms must post against derivatives transactions. While centralised clearing remains the core focus of these new regulations, more complex transactions – which remain in the bilateral space for the time being - will also face constraints.

The reforms will make credit support annexes (CSAs), which regulate the amount of collateral that firms need to post against derivatives trades, mandatory for OTC transactions. In the past, such agreements have been optional, although in practice, most firms chose to make use of them.

At the moment, buy-side firms can negotiate the type of collateral that they wish to post against derivatives trades, including corporate bonds and cash in various currencies. The new regulations will force companies to post high-quality liquid securities. A higher haircut will be imposed for certain types of collateral, such as that posted in a currency different to the underlying transaction. The new rules will also limit the amount of unsecured credit risk that each party can take, which at the moment is equivalent to a threshold set out under the CSA.

Despite a growing emphasis on centralised clearing, bilateral CSAs are likely to remain relevant for some time to come. Interest rate swaps will be centrally cleared, but for other products, it will not be possible to do so because of the nature of the business, according to Guido Hebert, global head of rates structuring with HSBC in London. "Clearing can only take place if the derivatives is standard and the market is broad and deep enough. For many products, this may not be the case," he says.

A more certain world

The introduction of tougher rules and a growing awareness of the dangers of counterparty risk are prompting large numbers of insurance companies to look at how CSAs might be rewritten in order to offer greater protection. Removal of counterparty risk is also important for investment banks with which the CSA is agreed.

"The reality is that investment banks and insurers are coming at this from the same place," says Paul Traynor, London-based head of custody bank BNY Mellon's Europe, Middle East and Africa (EMEA) insurance unit. "Both parties want to be protected. Party A doesn't want the risk of party B, just as party B doesn't want the risk of party A."

There are many areas, therefore, in which insurers and investment banks can find common ground for agreeing or renegotiating their CSAs. Reducing uncertainty and risk is one of the top priorities for all sides.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here